Upcoming Events
|
Boston Single Cell Network MeetingDana-Farber Cancer Institute Dana 1620 (Smith Family Room) Tuesday, Dec. 2 4:00-5:30 PM
The HSCI Technology Serieswas developed to best serve researchers in their day-to-day experimental work. Experts in up-and-coming protocols present and answer your questions. Please join us at future events: HSCI Technology Series: CRISPRSherman Fairchild 268 Thursday, Dec. 4 12:00-1:00 PM
|
People News
|
Zhigang He, PhD, a neurologist at Boston Children's Hospital, and Brian Wainger, MD, PhD, a neurologist at Massachusetts General Hospital, join as HSCI Principal Faculty members; Andrew Lane, MD, PhD, an oncologist at the Dana-Farber Cancer Institute, joins as an Affiliated Faculty member. Art student (the daughter of HSCRB's M. Willy Lensch, PhD) collaborates with George Daley Lab on Stem Cell Reports cover art.
|
|
HSCI-CIRM hold annual symposium
Stem Cells 2.0: Harvard/California, now in its eighth year, drives innovative research between CIRM/HSCI scientists
Forty principal investigators from Harvard and California gathered at Massachusetts General Hospital last week for a casual, annual symposium focused on discussing unpublished work, receiving critical feedback, and forming cross-country collaborations. Fernando Camargo, PhD, and David Langenau, PhD, co-organized this year's meeting. Read more.
|
Advances in gene-editing therapies
In two gene-editing studies, one team makes the first CRISPR/CAS9 edits in human blood cells, another finds a way to make future transplant-based therapies safer and more efficient
|
|
|
|